Objectives: The primary objective was to assess the prognostic significance of MR spectroscopy parameters (choline/NAA and choline/creatine ratio)both at Baseline (Pre operative MRS) and post adjuvant radiation regarding survival and its comparison with traditional anatomic MRI based grading parameters (enhancement quality, enhancement proportion, enhancement margin,T1 Flair Ratio).A secondary objective was to corelate any association between the MRS metabolic baseline and response values(cho/NAA and cho/creatine ) with Histopathologically proved recurrence. Materials and Methods: 25 histopathologically proved Grade III gliomas (astrocytomas and mixed oligoastrocytomas),registered in our institution between 2013-2016 who had both preoperative and post radiation MRI and MRS done were included in the study.MRS metabolic parameters were graded at baseline (Pre op) into cho/Naa ratio (>3.5,<3.5)and cho/creatine ratio(>2,<2) and at response(post adjuvant radiation) into cho/Naa change(>25%,<25% of baseline) and Cho/creatine (>10%,<10% of baseline). Baseline Anatomic MRI characteristics of the tumor (pre op) was also graded into enhancement quality (mild/avid), proportional enhancement(>50%,<50%), Margin of enhancement(well defined/poorly defined) and T1/Flair Size ratio(expansive/infiltrative)based on the VASARI/REMBRANDT MR feature set. PFS was estimated from time of completion of adjuvant treatment to clinical or radiological progression or last clinical follow up. Univariate analysis using Kaplan maier survival method and Log Rank value test was done for both the metabolic MRS value groups (baseline and Response) and the anatomic MRI parameters. Univariate survival analysis was also done to assess significance of Radiation dose (>50 Gy, <50 Gy) and extent of surgery (total vs subtotal/biopsy). Any parameter with log rank p value<0.08 was deemed to be significant and was entered into multivariate cox regression analysis. Histopathologically confirmed cases of recurrence (positive HPE/negative HPE) was correlated with baseline and response MRS value groups using Paired t test to corelate any significance. All analysis were done using SPSS-V23. Results: Median follow up period was 38 months &median pfs was 13.2 months. On univariate analysis of the baseline and response value groups of MRS, the most significant factor associated with better survival www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 JMSCR Vol||06||Issue||11||Page 765-773||November 2018 was cho/cr change greater than 10%(PFS of 22.1 months vs 9.3 months, log rank p value=0.002) followed by baseline cho/naa less than 3.5 (PFS of 21.7 months vs 12.7 months, p=0.021).Among the Anatomic MRI parameters well defined enhancement margin was associated with survival advantage (PFS 20.5 vs 12.3 months, p=0.045). Full RT dose and total excision both were individually associated with better survival (p=0.073 and p=0.002).On multivariate analysis only cho/cr change >10% was significant at p=0.144 among MRS parameters. Among the 7 patient who underwent rexcision following clinical/radiological progression,6 were HPE confirmed recurrence. On paired t test Cho/naa change>25% of baseline(post RT response value) was identified as the best predictor of HPE confirmed recurrence (p=0.008) better than radiological progression during Follow up(p=0.350) Conclusion: MRS metabolic parameters (Lower baseline cho/naa and greater cho/cr change after treatment) are of significant survival advantage whereas lesser cho/Naa response has better specificity for HPE proved recurrence than its anatomic counterpart. Prospective studies evaluating voxel based MRS data incorporated into treatment planning systems can be an interesting way forward.
Introduction
Prognosis of glial tumors is inherently complex with a significant number of factors contributing in an asymmetric and multidimensional way. The inclusion of genetic mutations in the WHO 2016 CNS tumor classification [1] has paved the roadway for newer criteria of risk stratification. However Response assessment with Traditional anatomical MRI imaging has its shortfall with the inability to measure the physiological and metabolic response of the Tumor to treatment. Although Sensitivity is equivalent or non-superior to, Specificity criteria in determining recurrence in response assessment studies which included Physiological and metabolic parameters like Diffusion weighted MRI [2] and MR Spectroscopy [3] are consistently higher. Response assessment in treated Grade II and Grade III Glioma most commonly is done using a combination of clinical symptoms and Anatomical MRI based evidence of progression [4] and is not commonly adjuncted with functional, physiological, and metabolic parameters as is commonly the case with GBM [5] .With the advent and ease of generating both structural features and metabolic functions in the same setting ,much more deeper insight into the individual tumor behaviour post treatment can be generated [6] with adjuction of spectroscopy to traditional anatomic MRI. The fusion of MRS metabolic data into primary treatment planning also showed increased total target volume with subsequent site modification to the boost volume, both of which was Predicted to be associated with Improved local control [7] Physiological and Metabolic character of the tumor in the pre treatment stage and their graded response post treatment is itself a recognised independent prognostic Factor [8] and their incorporation and correlation with other patient, tumor and treatment related factors have the potential to identify the cohort at risk for early recurrence. Voxel based progression studies have shown that higher choline NAA index voxels in pretreatment planning volumes have higher chance of recurrence [9] with moderate influence of dose escalation at those sites In our present study we have aimed to study the significance of Metabolic MR parameters (both at baseline and response level) as outcome predictor in Grade III Gliomas who received post operative adjuvant radiotherapy. Other objectives included comparison of strength of positive predictive association between Pre op anatomic MRI tumor features (as per REMBRANDNT) [10] to that of Baseline MRS values regarding progression free survival. Positive Predictive value of HPE proven recurrence was also comparatively correlated between radiological anatomic MRI based progression and Response value groups of MRS.
Materials and Methods
Inclusion Criteria: Retrospectively patient data was collected and the patient who fulfilled the following criteria was included in the study (table 1) Grade III Gliomas were enrolled in our study who had underwent either total/Subtotal excision or a biopsy and had a Pre op MRI and MRS (table 2) and were treated with adjuvant radiation. External beam radiation in our institution was done with Philips CT simulation wth slices of 3mm and then planning was done in Varian Eclipse Treatment planning system(v 13.1).A portion of the study population also received Adjuvant radiation in outside centres. In all 8 patients were treated with conformal radiation(3D CRT and IMRT),12 with CT simulation and volumetric treatment planning but treatment delivery in cobalt without Multi leaf colimeter and 5 were treated with 2D X-ray based simulation. Patients were treated with doses of 50-54 Gy in standard fractionation. Some Patients were treated with a hypofractionated schedule in phase I followed by phase II bringing the total dose to 50-54 Gy in EQD2.All patients received at least 50 Gy External beam radiation.13 patients received concurrent Temozolamide at 75 mg/m2/daily and only 3 patients, maintanence doses at 150-200 mg/m2 D1-5 in a 28 days cycle with an average of 4 cycles with the maximum of 6 cycle for 1.
MRS Metabolic parameters
Baseline (Pre OP) MR metabolic values of Choline/ Naa (ratio) were grouped as >3.5 and<3.5 for with the cutoff for the groups being the approximate median value of the baseline cho/naa ratio in the total patient population. Baseline values of Cho/cr(ratio) were also stratified into 2 groups with values>2 and <2 based on the approximate median value seen in the cohort . Response data from the post treatment MRS (the last one done)was calculated and grouped as decrease in cho/naa (ratio) >25% or<25% from baseline value based on previous literature data suggesting the subgroup with increased change has better DFS [11] median change in both the groups. Cho/cr (ratio) response from baseline also was grouped into >10% or<10% based on the median change from baseline in the population cohort 
Discussion
Metabolites quantifiable in a clinical MRS with a proven role in prognostic significance are choline(cho), N-acetylaspartate (NAA) and creatine (Cr) [12] . Whereas observer viewed different parameters of structural orientation of the tumor like midline shift, tumor diameter and patient and tumor factors like diameter, midline shift and objective patient and tumor related factors were both identified as of prognostic significance in Low grade Glioma [13] the anatomic features were not of that significant value in Grade III gliomas [14] .This literally paved the idea for increased focus on linear & individualisation of tumor characterisation with higher grades of Glioma, as in GBM we have an established significance for Functional imaging be it DOPA PET [15] or MR spectroscopy [16] .
In our current study we retrospectively identified Patients of WHO grade III gliomas of astrocytoma variant, who underwent post operative radiation, either in our institution or other with techniques ranging from 2d x ray based simulation to IMRT, however within this wide spread range of Radiation Techniques ,in our inclusion criteria we maintained a homogenous intake which was, availability of at least 1 Pre operative MRI (at least T1 and T2 sequences) & MRS and 1 MRS post adjuvant radiation (92% was within 6 months of finishing adjuvant radiation)(Both multivoxel/CSI or single voxel) but about 90% of our MRS data both Pre operative and Adjuvant radiation were based on Multivoxel data, probably signifying the in homogeneity of metabolites that Grade III gliomas produce due to their increased infiltrative pattern [17] . Also regarding the use of absolute concentrations vis a vis the ratios in terms of both initial grading and in prognosis [18] , although normalized value of Creatine has been established as a prognostic factor at baseline [19] ,in other studies regarding increased survival after adjuvant radiation, cho/cr response pattern were deemed to be of significance [20] . Infact Quon et al, showed that >40% change in normalized choline from week 4 to 2 months post RT was associated with both poor OS and PFS. In our study we could not provide both normalized and metabolite ratios in terms of significance due to lack of standardized MRS reporting system in our cohort. As patients were recruited retrospectively based on availability of pre op and post Radiation MRS data, standardization and uniformity regarding the radiotherapy techniques couldn't be ascertained, and this might have a influence on the response patterns 21 . In our study population 8 patients underwent conformal radiation (3DCRT and IMRT), 12 patients were treated with CT simulation and volumetric Treatment planning with treatment being delivered in cobalt machine without Multi leaf colimeter and 5 patients were treated with conventional 2D xray simulation. The assessment of Cho/cr ratio response value Post adjuvant radiation as a significant prognostic factor for increased progression free survival in our study goes well with the established literature [22] . Increased Baseline Cho/NAA shown in our study linked to poor survival, which has been reported as of significant prognosis in newly diagnosed GBM [23] ,this has not been labelled of significance in Grade III gliomas until now. Cho/NAA index at the time of diagnosis is highest in grade III gliomas [24] , owing to increased choline concentration due to increased cell membrane densities(compared to Grade II gliomas) and a concurrent decrease in NAA concentration due to the increased infiltrative character(again compared to Grade II).In Grade 4 (GBM), as most of the tumor mass is formed of the necrotic volume, the metabolite index values are generally low [25] . This hypothesis of tumor physiology is probably reflected in our recurrence data too, where decrease in Cho/Naa index less than 25 % of baseline post adjuvant radiation, shows significant association with post rexcision HPE proven recurrence, compared to radiological progression. Traber et all showed that focal choline accumulation early after adjuvant radiation was umambigously predicting recurrence in High grade gliomas. Change in Cho/NAA index in Grade III gliomas, among all other grades, probably reflect the percentage reduction of functional tumor core, in the most significant manner, owing to the highest metabollicaly active to necrotic volume ratio. As Recurrence in Grade III gliomas in mostly within the Treated field 26 ,our study iterates the fact that prospective studies incorporating, the voxel based functional imaging data incorporated into the treatment volumes, might bring about better local control. Pirzkall et al (2001) showed that incorporation of MRSI data into anatomic MRI based radiotherapy treatment volumes alter both the primary treatment and the boost volume which was relatively validated in a study by Ballengrud (2011). Voxel based progression studies have shown choline NAA index (CNI) having the greatest association with recurrence, better than DWI parameters like ADC 27 . Zhang et all have shown incorporation of 3D-MRSI data have improved the primary surgical extent delineation in glioma surgery However till date no prospective study has shown survival advantage in HCG incorporating MRSI data in treatment volume. As data was collected retrospectively In our study we couldn't estimate the role of surgery in the extent of response in MRS metabolite index, as most of the MRS were probably done during either routine follow up, or or clinical and radiological progression post adjuvant radiation, however as suggested post surgical MRS signal is most probably due to residual tumor margin, as opposed to post surgical change 28 . The overall prognostic significance parameters of MR spectroscopic metabolic index as compared to traditional anatomic MRI done in our Study is in concordance with established literature [29] . As a retrospective data push, it suggests incorporation of Functional parameters into treatment planning by means of software development. Although PET and planning CT fusion has been reported to improve GTV delineation, geographic misses, and a reduction in organ at risk doses [30] , Integrated PET/CT simulation centres are few in number and of huge cost. CT-MR fusions have become a standard in treatment of Gliomas using linear accelerator, and incorporating MRS data taken at the same time as of diagnostic MRI seems to be of much cost effective method, if routine radiotherapy planning software starts incorporating them.
